GRANT PROGRESS: A Web-based Assessment of Visual and Spatial Symptoms of Parkinson’s Disease: Amick, 2008
Michael J. Fox Foundation Awards $1 Million to Develop and Validate Web-based Clinical Assessments for Parkinson's Disease
Melissa Amick, MHRI
03 Nov 2009
9/15/2009 INTERIM PROGRESS REPORT Associated Posts:grant award press release abstract ... 
GRANT PROGRESS: Wearable Sensors and a Web-Based Application to Monitor Patients with Parkinson’s Disease in the Home Environment: Bonato, 2008
Michael J. Fox Foundation Awards $1 Million to Develop and Validate Web-based Clinical Assessments for Parkinson's Disease
Paolo Bonato, Harvard
03 Nov 2009
9/21/2009 INTERIM PROGRESS REPORT Associated Posts:grant award press release abstract  ... 
GRANT PROGRESS: Developing and Validating Spanish Language Web-based Clinical Assessments for Parkinson’s Disease: Cubo, 2008
Michael J. Fox Foundation Awards $1 Million to Develop and Validate Web-based Clinical Assessments for Parkinson's Disease
Esther Cubo, HGY
03 Nov 2009
9/7/2009 INTERIM PROGRESS REPORT Associated Posts:grant award press release abstract  ... 
How do we define mild cognitive impairment (MCI)?
Are existing psychiatric and cognitive assessment scales adequate for use in clinical trials of PD treatments? Do better PD-specific scales need to be developed, and how can they be validated?
Holli Kawadler, The Michael J. Fox Foundation for Parkinson's Research
08 Oct 2009
An interesting discussion arose at a recent MJFF Awardee Meeting regarding assessing mild cognitive impairment in Parkinson's disease (PD-MCI). Cognition decribes a very complex set of functions, but ... 
GRANT PROGRESS: Can the Electrocardiogram be Used to Identify Pre-motor Parkinson’s Disease? Langston, 2008
Rapid Response Innovation Awards 2008
J William Langston, The PI, et al.
12 Sep 2009
9/12/2009 FINAL OUTCOMES REPORT Associated Posts: grant award announcement abstract ... 
GRANT PROGRESS: Online Motor and Cognitive Analysis System: Alberts, 2008
Michael J. Fox Foundation Awards $1 Million to Develop and Validate Web-based Clinical Assessments for Parkinson's Disease
Jay L Alberts, Cleveland Clinic
12 Sep 2009
9/12/2009 INTERIM PROGRESS REPORT Associated Posts: grant award press releaseabstract ... 
Frequency vs. severity of non-motor symptoms of PD
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease.
Kirsten Carlson, The Michael J. Fox Foundation for Parkinson's Research
15 Jun 2009
This paper describes a large, comprehensive study aimed at determining primarily the prevalence of various non-motor symptoms of PD. Results indicate the most frequently reported of these ... 
MDS 13th International Congress, live report 6/7/09: Assessing cognitive abilities
Are existing psychiatric and cognitive assessment scales adequate for use in clinical trials of PD treatments? Do better PD-specific scales need to be developed, and how can they be validated?
Alison Urkowitz, The Michael J. Fox Foundation for Parkinson's Research
07 Jun 2009
At today's "Management of neuropsychiatric non-motor aspects" session at MDS, chaired by Paolo Barone and Marcelo Merello, discussions touched on the scales to use when measuring cognitive abilities ... 
Clinical Scales: validation - not specification - is key
Are existing psychiatric and cognitive assessment scales adequate for use in clinical trials of PD treatments? Do better PD-specific scales need to be developed, and how can they be validated?
Kirsten Carlson, The Michael J. Fox Foundation for Parkinson's Research
05 Jun 2009
From the previously posted responses by Dr. Leentjens and Dr. Marras, it seems that what is needed isn't a collection of scales developed specifically for PD, but scales that have been ... 
Do we need to develop PD specific psychiatric and cognitive assessment instruments?
Are existing psychiatric and cognitive assessment scales adequate for use in clinical trials of PD treatments? Do better PD-specific scales need to be developed, and how can they be validated?
Albert FG Leentjens, Maastricht
01 May 2009
No. And perhaps in some instances: yes. The development of PD specific assessment instruments should not be an aim in itself, but serve clear clinical and/or research purposes. In the most common ...